Blue background

Privacy Notice

Last Revised on January 4, 2023


Corcept Therapeutics Incorporated and its subsidiaries and affiliates (together, “Corcept,” “we”, “our”, “us”) are committed to protecting and respecting your privacy. The purpose of this Privacy Notice is to provide you with information on how we will collect, use, disclose, protect, and otherwise process personal information and explain the rights and choices available to individuals with respect to their personal information. We are a public company established in the United States (the “US”) with a registered office at 149 Commonwealth Drive, Menlo Park, CA 94025, and, for the purposes of the General Data Protection Regulation (the “GDPR”) and the United Kingdom’s Data Protection Act 2018 (including the UK General Data Protection Regulation (“UK GDPR”)), we are the data controller.

This Privacy Notice sets out the basis on which we will process personal information or usage information we collect from you, or that you provide to us, in connection with your use of the following Corcept websites and related services or relationships described herein:

  •; and
  • Social media or online platforms hosted by Corcept (e.g., Cushing’s Connection on Facebook)

(together, the “Sites” and each a “Site”).

We may provide additional privacy notices to different categories of individuals at the time we collect their data, including as follows:

  • If you are an employee or contractor of Corcept, please refer to the privacy notice we provided to you at the start of your employment/engagement with us (as it may be amended and updated from time to time), which can also be accessed on our internal portal.
  • If you are a participant in a clinical trial, please refer to the informed consent document provided to you in connection with your participation in the clinical trial (if needed, ask the physician responsible for the clinical trial for a copy).
  • If you are a clinical investigator or study personnel engaged by us (or by a contract research organization on our behalf) in connection with a clinical trial sponsored by us, please refer to the specific privacy notice to clinical trial investigators and study personnel.
  • If you are a participant in our Patient Advocate Support program or our Support Program for Access and Reimbursement for Korlym (SPARK), our use and disclosure of your health-related information and other personal information will be pursuant to the Patient Consent and HIPAA Authorization that you have signed as part of the Patient Enrolment Form.
  • If you are a clinical investigator submitting a proposal for our Investigator-Initiated Studies Program, please note that this is hosted outside of our Sites and that your submissions will be subject to Benevity Privacy Policy which can be accessed at

Please read this notice carefully so that you understand your rights in relation to your personal information, and how we will collect, use and process your personal information. If there is any conflict between this notice and a separate, more specific privacy notice provided to you by Corcept, you should rely on the more specific notice to determine your rights and how your data will be used and processed.

We do not “sell” your personal information in the traditional sense of the word “sale.” We may, however, share certain information about you with contracted third-parties to provide better services and advertising to you. You may opt out of sharing this information, by contacting us via the “How to Contact Us” section below.

Please note that if you consented to receiving text messages from us (e.g., as part of our Patient Advocate Support program), your telephone number will not be shared with third-parties for marketing purposes.

If you do not agree with this Privacy Notice in general or any part of it, you should not access the Sites.